Jennifer M Jones

Jennifer M Jones, PhD

Dr. Jones' research program has focused primarily on the quality of life and psychosocial issues of individuals and families facing cancer. Her most recent scholarly and professional activities have clustered around the following platforms:
  • Translational research to inform clinical survivorship care
    This platform specifically focuses on examining new approaches to predict, prevent and manage long-term adverse effects of cancer and its treatment and evaluating innovative models of follow-up care and support. This includes: i) Assessment of the prevalence and impact of long-term and late physical and psychosocial effects of cancer and its treatment; ii) Development and evaluation of sustainable and cost-effective psychosocial and self-management interventions for patients and their families and innovative models of care; 3) Integration of evidence into daily clinical practice through the development of integrated KT models and education.
  • Fostering innovative health professional and continuing education that is designed to transform the patient experience
    This area of research has included the development and formal evaluation of multidisciplinary training programs in psychosocial oncology and palliative care, patient education, and cancer survivorship care.

Related Links

Support Care Cancer. 2018 Mar 12;:
Tsang DS, Jones JM, Samadi O, Shah S, Mitsakakis N, Catton CN, Jeon W, To J, Breunis H, Alibhai SMH
Cancer. 2017 Dec 06;:
Alibhai SMH, Breunis H, Timilshina N, Hamidi MS, Cheung AM, Tomlinson GA, Manokumar T, Samadi O, Sandoval J, Durbano S, Warde P, Jones JM
JMIR Res Protoc. 2017 Aug 24;6(8):e165
Ritvo P, Obadia M, Santa Mina D, Alibhai S, Sabiston C, Oh P, Campbell K, McCready D, Auger L, Jones JM
Thyroid. 2017 Aug 14;:
Alhashemi A, Jones JM, Goldstein DP, Santa Mina D, Thabane L, Sabiston CM, Chang EK, Brierley JD, Sawka AM
Contemp Clin Trials. 2017 May 30;:
Carlson LE, Zelinski EL, Speca M, Balneaves LG, Jones JM, Mina DS, Wayne PM, Campbell TS, Giese-Davis J, Faris P, Zwicker J, Patel K, Beattie TL, Cole S, Toivonen K, Nation J, Peng P, Thong B, Wong R, Vohra S
Eur Urol. 2017 May 08;:
Jones JM, Bhatt J, Avery J, Laupacis A, Cowan K, Basappa NS, Basiuk J, Canil C, Al-Asaaed S, Heng DYC, Wood L, Stacey D, Kollmannsberger C, Jewett MAS
J Clin Oncol. 2016 Jan 20;34(3_suppl):183
Alton D, Song Y, Farzanfar D, Krys O, Yoannidis T, Milne R, Habbous S, Brown MC, Vennettilli A, Shepherd FA, Leighl NB, Hope AJ, Howell D, Jones JM, Selby P, Xu W, Goldstein DP, Giuliani ME, Liu G
J Clin Oncol. 2016 Jan 20;34(3_suppl):120
McQuestion M, Sampson L, Le LW, Jones JM, Cheng T, Waldron JN, Ringash J
Curr Oncol. 2016 Dec;23(6):e546-e555
Naik H, Qiu X, Brown MC, Eng L, Pringle D, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Jones JM, Howell D, Liu G


Director, Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre
Associate Professor, Department of Psychiatry (primary) and Dalla Lana School of Public Health (cross-appointment), University of Toronto
Co-Lead, Canadian Cancer Survivorship Research Consortium (